ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
clearpoint neuro 第二季度2024年GAAP每股收益爲$(0.16)，超過$(0.20)的估計，銷售額爲$7,858,000，超過$7,330,000的估計。
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 44.83 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $7.858 million which beat the analyst consensus estimate of $7.330 million by 7.21 percent. This is a 32.07 percent increase over sales of $5.950 million the same period last year.
ClearPoint Neuro (納斯達克：CLPT) 報告季度虧損每股 $(0.16)，超過分析師預期的 $(0.20) 的20%。這比去年同期每股虧損 $(0.29) 增加了 44.83%。該公司報告的季度銷售額爲 $785.8萬，比分析師預期的 $733萬 高了 7.21%。這是去年同期銷售額 $595萬 的增長了 32.07%。